Document Type and Number:
Japanese Patent JPWO2022025298
Kind Code:
A1
Abstract:
The present invention provides a recombinant vaccinia virus serving as a clinically usable preventive vaccine for COVID-19 (vaccine for SARS-CoV-2), etc.The recombinant vaccinia virus of the present invention is characterized by comprising the whole or part of cDNA encoding nonstructural proteins or structural protein derived from SARS-CoV-2, and an expression promoter.
Application Number:
JP2022539632A
Publication Date:
February 03, 2022
Filing Date:
July 30, 2021
Export Citation:
